Radiopharmaceutical Identity, Dose, and Route of Administration
| Identity | Dose | Route of administration |
|---|---|---|
| 99mTc-MAG3 (recommended) or… | 74 MBq (2 mCi); range: 37–185 MBq (1–5 mCi) | Intravenous |
| 99mTc-diethylenetriamine pentaacetic acid | 185 MBq (5 mCi); range: 185–370 MBq (5–10 mCi) | Intravenous |
| Pediatric dose: 99mTc-MAG3 | Without flow study: 3.7 MBq/kg (0.10 mCi/kg); with flow study: 5.55 MBq/kg (0.15 mCi/kg); minimum administered activity: 37 MBq (1.0 mCi); maximum administered activity: 148 MBq (4 mCi) | Intravenous |
| Furosemide (based on creatinine level; mg/dL) | Intravenous | |
| 1.0 | 20 mg | |
| >1.5 | 40 mg | |
| 2.0 | 60 mg | |
| 3.0 | 80 mg | |
| Pediatric dose: furosemide | 1 mg/kg to maximum of 40 mg | Intravenous |
MAG3 = mercaptoacetyltriglycine.
99mTc-MAG3 is preferred tracer in patients with known impaired renal function.